CClinicalTrials.gg
CompletedNCT05688228VTOPSimpactUpdated May 8, 2024

Voluntary Interruption of Pregnancy on Women's Sexuality

An observational study in Abortion, sponsored by University Hospital, Bordeaux. Completed at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-08.

Sponsored by University Hospital, Bordeaux · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
209
Ages
18 Years and older
Sex
Female
01

Study summary

The impact on sexuality has been less studied and there is no French study on this subject and the rare studies are contradictory.

The aim of this study is to evaluate the impact of abortion (medical or surgical) on female sexuality, to look for a difference in the impact on sexuality according to the method used for the termination (medical or surgical) just after the procedure and at 1, 3 and 6 months and to look for risk factors and protective factors for the existence or occurrence of sexual dysfunction before and after abortion.

Read the detailed description

The medical consequences of abortion are low. However, there is an undeniable emotional and psychological impact on these women (40-45% of anxiety-type symptoms, approximately 20% of depressive symptoms after the discovery of the pregnancy and 30% of emotional disorders, particularly anxiety, in the month following the abortion).

The impact on sexuality has been less studied and there is no French study on this subject and the rare studies are contradictory.

The aim of this study is to evaluate the impact of voluntary termination of pregnancy (medical or surgical) on female sexuality, to look for a difference in the impact on sexuality according to the method used for the termination (medical or surgical) just after the procedure and at 1, 3 and 6 months and to look for risk factors and protective factors for the existence or occurrence of sexual dysfunction before and after a termination.

02

Conditions studied

  • Abortion

Keywords

  • Abortion
  • Female sexuality
  • FSFI
03

In context

Lead sponsor

University Hospital, Bordeaux is the lead sponsor of 783 studies on the registry; 188 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women performing a medical or surgical abortion

Inclusion criteria

  • Adult patient (≥ 18 years)
  • Patient performing a medical or surgical abortion
  • Patient with health insurance
  • No opposition to participation in the study

Exclusion criteria

Exclusion Criteria:

  • Patient who does not speak French and/or is illiterate
  • Patient under legal protection
  • Patient unable to complete the study procedures (no internet connection, no smart phone or tablet)
  • Patient with diagnosed psychiatric comorbidities.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
209 participants (actual)
Patient registry
No

Groups and cohorts

  • Abortion

    Adult women performing a medical or surgical abortion

    Other: questionnaire

Interventions

  • Otherquestionnaire

    Female Sexual Function Index (FSFI) and self-administrative questionnaires on sexuality just after abortion and repeated at 1, 3 and 6 months

06

What researchers measure

Primary outcomes

  1. Number of patients with sexual dysfunction

    Sexual dysfunction is assessed using the Female Sexual Function Index (FSFI) questionnaire, which takes into account several aspects of female sexuality: desire, arousal, lubrication, orgasm, satisfaction and pain. The threshold for differentiating between patients with and without sexual dysfunction is 26.55

    Time frame: Month 6

Secondary outcomes

  1. Marital status

    single, couple, married

    Time frame: Baseline

  2. Number of sexual partners in the last 12 months

    Number of sexual partners via self-questionnaire : 1 ; from 2 to 5 ; from 6 to 10 ; from 11 to 15 ; from 16 to 20 ; up to 20

    Time frame: Baseline

  3. Number of sexual partners in the whole life

    Number of sexual partners via self-questionnaire : 1 ; from 2 to 5 ; from 6 to 10 ; from 11 to 15 ; from 16 to 20 ; up to 20

    Time frame: Baseline

  4. Number of sexual partners in the last 4 weeks

    Number of sexual partners via self-questionnaire : 0, 1, from 2 to 5, up to 5

    Time frame: Baseline

  5. Frequency of sexual activity in the last month before pregnancy discovery

    \< 1 /month ; from 1 from 3 /month ; 1 /week ; twice /week ; 3 or more times /week

    Time frame: Baseline, Month 1, Month 3, Month 6

  6. Existence of physical violence in the whole life

    binary variable (yes/no)

    Time frame: Baseline

  7. Existence of psychological violence in the whole life

    binary variable (yes/no)

    Time frame: Baseline

  8. Existence of sexual violence in the whole life

    binary variable (yes/no)

    Time frame: Baseline

  9. Existence of psychological symptoms before pregnancy's discovery

    asthenia, sadness, anxiety, guilt, none

    Time frame: Baseline

  10. Existence of psychological symptoms in the last month

    asthenia, sadness, anxiety, guilt, none

    Time frame: Month 1, Month 3, Month 6

  11. Existence of sexual difficulties since pregnancy's discovery

    Decreased desire, arousal, lubrication, quantity or quality of orgasms, sexual satisfaction or relationship with the partner, appearance or increase of pain during sexual intercourse, no change in these different areas of sexuality

    Time frame: Baseline

  12. Sexual activity the last month

    Decreased sexual activity (fear of another pregnancy, waiting to start contraception, conflict with partner after abortion, other reason), Not concerned about decreased sexual activity

    Time frame: Month 1, Month 3, Month 6

  13. Contraception in the last month

    none, removal/cycles, condoms, pill, intrauterine devic, implant, ring/patch, other

    Time frame: Month 1, Month 3, Month 6

07

Study locations

1 site
  • CHU Bordeaux
    Bordeaux, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05688228
Lead sponsor
University Hospital, Bordeaux
Responsible party
Sponsor
First posted
Jan 18, 2023
Start date
Feb 27, 2023
Primary completion
Feb 10, 2024
Completion
Feb 10, 2024
Last update
May 8, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion